Zastrozhin M.S. - Publications list

Records list

Show:

TRACKING DEVELOPMENT ASSISTANCE FOR HEALTH AND FOR COVID-19: A REVIEW OF DEVELOPMENT ASSISTANCE, GOVERNMENT, OUT-OF-POCKET, AND OTHER PRIVATE SPENDING ON HEALTH FOR 204 COUNTRIES AND TERRITORIES, 1990-2050

Article

Micah A.E., Cogswell I.E., Cunningham B., Ezoe S., Harle A.C., Maddison E.R., Mccracken D., Nomura S., Simpson K.E., Stutzman H.N., Tsakalos G., Wallace L.E., Zhao Y.X., Zende R.R., Abbafati C., Abdelmasseh M., Abedi A., Abegaz K.H., Abhilash E.S., Abolhassani H. ...

Lancet. Vol. 398. 2021. P.. 1317-1343

GLOBAL, REGIONAL, AND NATIONAL PROGRESS TOWARDS SUSTAINABLE DEVELOPMENT GOAL 3.2 FOR NEONATAL AND CHILD HEALTH: ALL-CAUSE AND CAUSE-SPECIFIC MORTALITY FINDINGS FROM THE GLOBAL BURDEN OF DISEASE STUDY 2019

Article

Paulson K.R., Kamath A.M., Alam T., Bienhoff K., Abady G.G., Abbas J., Abbasi-Kangevari M., Abbastabar H., Abd-Allah F., Abd-Elsalam S.M., Abdoli A., Abedi A., Abolhassani H., Abreu L.G., Abu-Gharbieh E., Abu-Rmeileh N.ME., Abushouk A.I., Adamu A.L., Adebayo O.M., Adegbosin A.E. ...

Lancet. Vol. 398. 2021. P.. 870-905

INFLUENCE OF PLASMA CONCENTRATION OF HSA-MIR-370-3P AND CYP2D6*4 ON EQUILIBRIUM CONCENTRATION OF PHENAZEPAM IN PATIENTS WITH RECURRENT DEPRESSIVE DISORDER T

Article

Zastrozhin M.S., Efimova A.V., Skryabin V., Smirnov V.V., Petukhov A.E., Pankratenko E.P., Pozdniakov S.A., Kaverina E.V., Klepikov D.A., Grishina E.A., Ryzhikova K.A., Burev I.V., Bryun E.A., Sychev D.A.

Psychopharmacology bulletin. Vol. 51. 2021. P.. 87-104

IMPACT OF THE OMICS-BASED BIOMARKERS ON THE FLUVOXAMINE’S STEADY-STATE CONCENTRATION, EFFICACY AND SAFETY IN PATIENTS WITH AFFECTIVE DISORDERS COMORBID WITH ALCOHOL USE DISORDER

Article

Zastrozhin M.S., Skryabin V., Smirnov V., Zastrozhina A.K., Kaverina E.V., Klepikov D.A., Grishina E.A., Ryzhikova K.A., Bure I.V., Bryun E.A., Sychev D.A.

Psychopharmacology bulletin. Vol. 51. 2021. P.. 69-80

GLOBAL AGE-SEX-SPECIFIC FERTILITY, MORTALITY, HEALTHY LIFE EXPECTANCY (HALE), AND POPULATION ESTIMATES IN 204 COUNTRIES AND TERRITORIES, 1950–2019: A COMPREHENSIVE DEMOGRAPHIC ANALYSIS FOR THE GLOBAL BURDEN OF DISEASE STUDY 2019

Article

Abbafati C., Machado D.B., Cislaghi B., Salman O.M., Karanikolos M., Mckee M., Abbas K.M., Brady O.J., Larson H.J., Trias-Llimós S., Cummins S., Langan S.M., Sartorius B., Hafiz A., Jenabi E., Borzouei S., Azarian G., Khazaei S., Abbasi M., Asghari B. ...

Lancet. Vol. 396. 2020. P.. 1160-1203

FIVE INSIGHTS FROM THE GLOBAL BURDEN OF DISEASE STUDY 2019

Article

Lancet. Vol. 396. 2020. P.. 1135-1159

GLOBAL BURDEN OF 369 DISEASES AND INJURIES IN 204 COUNTRIES AND TERRITORIES, 1990-2019: A SYSTEMATIC ANALYSIS FOR THE GLOBAL BURDEN OF DISEASE STUDY 2019

Article

Abbafati C., Abbas K.M., Abbasi M., Abbasifard M., Abbasi-Kangevari M., Abbastabar H., Abd-Allah F., Abdelalim A., Abdollahi M., Abdollahpour I., Abedi A., Abedi P., Abegaz K.H., Abolhassani H., Abosetugn A.E., Aboyans V., Abrams E.M., Abreu L.G., Abrigo M.RM., Abu Haimed A.K. ...

Lancet. Vol. 396. 2020. P.. 1204-1222